Oral L-Carnitine: Metabolite Formation and Hemodialysis
The DOI matches its Crossref record.
Abstract
L-Carnitine has important roles in intermediary metabolism and patients with end-stage renal disease who are undergoing hemodialysis may develop a secondary L-carnitine deficiency. The extent of accumulation of the metabolites trimethylamine and trimethylamine-N-oxide when L-carnitine is administered orally has not been investigated previously in this population. Oral L-carnitine at a dose of 1 g daily was administered for twelve days to six patients with end-stage renal disease undergoing hemodialysis thrice weekly. Pre-dialysis plasma concentrations of L-carnitine (mean +/- SD) increased significantly (P < 0.05) from day 1 (baseline; 32.4 +/- 6.1 microM) to day 8 (66.1 +/- 13.8 microM) remaining constant thereafter. Although plasma levels of trimethylamine remained unaltered, the pre-dialysis plasma concentrations of trimethylamine-N-oxide increased significantly (P < 0.05) from day 1 (289.1 +/- 236.1 microM) to day 12 (529.0 +/- 237.9 microM). The hemodialysis clearances for L-carnitine, trimethylamine and trimethylamine-N-oxide were 14.3 +/- 8.2, 14.1 +/- 10.6 and 12.4 +/- 5.4 L/h, respectively, indicating their efficient removal by dialysis. Oral administration of L-carnitine at a dose of 1 g daily increases plasma concentrations of this substance to physiological levels in patients with end-stage renal disease who are undergoing hemodialysis. However, concerns about the possible deleterious consequences of such a dosage regimen still remain given that plasma concentrations of trimethylamine-N-oxide were continually rising and approximately doubled in a two-week period.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TMAO is cleared by the kidney, and prior studies have reported TMAO is elevated in subjects with impaired renal function16–18.”
In the citing paper
“TMAO is cleared by the kidney, and prior studies have reported TMAO is elevated in subjects with impaired renal function16–18.”
In the citing paper
“L-carnitine is a TMA nutrient that, in contrast to choline, is not required in our diets, since it is endogenously produced in mammals from dietary lysine, the single most abundant amino acid in plant and animal proteins (30,63,64).”
From The contributory role of gut microbiota in cardiovascular disease (2014) · cites this paper as [64]
Citations
Cites
Still being checked.
Cited by
Tang, W. H. W., Wang, Z., Kennedy, D. J., Wu, Y., Buffa, J. A., Agatisa-Boyle, B., Li, X. S., Levison, B. S., & Hazen, S. L. (2015) · Circulation Research · doi:10.1161/circresaha.116.305360 · Cited by 1,223
The contributory role of gut microbiota in cardiovascular disease
Tang, W. H. W., & Hazen, S. L. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72331 · Cited by 641
Carnitine and Acylcarnitines: Pharmacokinetic, Pharmacological and Clinical Aspects
Reuter, S. E., & Evans, A. M. (2012) · Clinical Pharmacokinetics · doi:10.1007/bf03261931 · Cited by 493
Self-citationThe gut microbiome, diet, and links to cardiometabolic and chronic disorders
Aron-Wisnewsky, J., & Clément, K. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2015.191 · Cited by 325
Fatigue in multiple sclerosis – Insights into evaluation and management
Ayache, S. S., & Chalah, M. A. (2017) · Neurophysiologie Clinique/Clinical Neurophysiology · doi:10.1016/j.neucli.2017.02.004 · Cited by 161
Microbiome, trimethylamine N-oxide, and cardiometabolic disease
Tang, W. H. W., & Hazen, S. L. (2017) · Translational Research · doi:10.1016/j.trsl.2016.07.007 · Cited by 160
Ghannoum, M., Laliberté, M., Nolin, T. D., MACTIER, R. A., Lavergne, V., Hoffman, R. S., Gosselin, S., & Workgroup, O. B. O. T. E. (2015) · Clinical Toxicology · doi:10.3109/15563650.2015.1035441 · Cited by 131
Nutrients Turned into Toxins: Microbiota Modulation of Nutrient Properties in Chronic Kidney Disease
Fernández-Prado, R., Esteras, R., Pérez-Gómez, M. V., Gracia-Iguacel, C., González‐Parra, E., Sanz, A. B., Ortíz, A., & Sánchez-Niño, M. D. (2017) · Nutrients · doi:10.3390/nu9050489 · Cited by 121
Identification and Characterization of Trimethylamine-N-oxide Uptake and Efflux Transporters
Teft, W. A., Morse, B. L., Leake, B. F., Wilson, A. S., Mansell, S. E., Hegele, R. A., Ho, R. H., & Kim, R. B. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00937 · Cited by 91
Inflammation and l-carnitine therapy in hemodialysis patients: a review
Khalatbari‐Soltani, S., & Tabibi, H. (2014) · Clinical and Experimental Nephrology · doi:10.1007/s10157-014-1061-3 · Cited by 41
L-Carnitine Ameliorates Glycerol-Induced Myoglobinuric Acute Renal Failure in Rats
Üstündağ, S., Şen, S., Yalcin, O., Ciftci, S., Demirkan, B., & Türe, M. (2009) · Renal Failure · doi:10.1080/08860220802599130 · Cited by 41
yuzefpolskaya, M., Bohn, B., Javaid, A., Mondellini, G. M., Braghieri, L., Pinsino, A., Onat, D., Cagliostro, B., Kim, A. D., Takeda, K., et al. (2021) · Circulation Heart Failure · doi:10.1161/circheartfailure.120.007909 · Cited by 27
Levocarnitine Decreases Intradialytic Hypotension Episodes: A Randomized Controlled Trial
Ibarra‐Sifuentes, H. R., del Cueto-Aguilera, Á. N., Gallegos‐Arguijo, D. A., Castillo‐Torres, S. A., Vera‐Pineda, R., Martínez‐Granados, R. J., Atilano‐Díaz, A., Cuéllar-Monterrubio, J. E., Pezina‐Cantú, C., Martínez‐Guevara, E. D. J., et al. (2017) · Therapeutic Apheresis and Dialysis · doi:10.1111/1744-9987.12553 · Cited by 21
Jafari, A., Khatami, M., Dashti‐Khavidaki, S., Lessan‐Pezeshki, M., Abdollahi, A., & Moghaddas, A. (2017) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2016.11.002 · Cited by 20
Khosroshahi, H. T., Habibiasl, B., Habibzadeh, A., Chaichi, P., Ghanbarpour, A., & Badie, A. H. (2013) · Nephro-Urology Monthly · doi:10.5812/numonthly.10670 · Cited by 17
Sengupta, A., Basant, A., Ghosh, S., Sharma, S., & Sonawat, H. M. (2011) · Journal of Parasitology Research · doi:10.1155/2011/901854 · Cited by 17
Trimethylamine generation in patients receiving hemodialysis treated with L-carnitine
Ozasa, H., Shimizu, M., Koizumi, A., Wakabayashi, A., & Yamazaki, H. (2014) · Clinical Kidney Journal · doi:10.1093/ckj/sfu045 · Cited by 11
Sánchez-Niño, M. D., & Ortíz, A. (2014) · Clinical Kidney Journal · doi:10.1093/ckj/sfu099 · Cited by 11
Кучменко, Т. А., Dorovskaya, E. S., Menzhulina, D. A., & Chubarov, T. V. (2022) · Journal of Analytical Chemistry · doi:10.1134/s1061934822120073 · Cited by 4
Кучменко, Т. А., Menzhulina, D. A., & Murakhovskii, I. A. (2023) · Journal of Analytical Chemistry · doi:10.1134/s1061934823080105 · Cited by 3
Pharmacological Adjuvants to Limit Erythropoietin Stimulating Agents Exposure
Masood, I., & Teehan, G. S. (2012) · Open Journal of Nephrology · doi:10.4236/ojneph.2012.24015 · Cited by 3
Кучменко, Т. А., Menzhulina, D. A., & Murakhovskii, I. A. (2023) · Journal of Analytical Chemistry · doi:10.31857/s0044450223080108 · Cited by 2
Bruzell, E. M., Steffensen, I., Granum, B. B., Hetland, R. B., Husøy, T., Rohloff, J., & Wicklund, T. (2015) · BIBSYS Brage (BIBSYS (Norway)) · doi:10.13140/rg.2.2.34736.87044 · Cited by 2
L-CARNITINE SUPPLEMENTATION IN UREMIC PATIENTS (LETTER TO EDITOR)
Zohreh, R., & Nemati, E. (2011) · Nephro-Urology Monthly · Cited by 1
Siddiqui, A. M., Siddiqui, A., & Benz, R. L. (2012) · InTech eBooks · doi:10.5772/26493
HUMAN GUT MICROBIOTA AND ITS EFFECTS ON HUMAN HEALTH IN NORMAL AND PATHOLOGICAL CONDITIONS
Munteanu, A. M., Cursaru, R., Guja, L., Carniciu, S., Borcan, A. M., & Popescu‐Spineni, D. (2017) · Romanian Medical Journal · doi:10.37897/rmj.2017.3.2
Physiopathologie et traitement de la fatigue dans la sclérose en plaques
Chalah, M. A. (2019) · theses.fr (ABES) · doi:10.70675/9be71a74z7578z4637za069zf44a656eb777
Nakayama, N. (2026) · Springer eBooks · doi:10.1007/978-981-95-7797-2_9
Haarhuis, J. E., Ahn‐Jarvis, J. H., Savva, G. M., Day-Walsh, P. E., Ferns, C., Hughes, S., Triller, S., Al-Jaibaji, O., Philo, M., Acaröz, E., et al. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1822840
The clinical impact of an altered endogenous carnitine profile
Reuter Lange, S. E. (2011) · Adelaide Research & Scholarship (AR&S) (University of Adelaide)
Metadata
- Authors
- Bain, M., Faull, R., Milne, R., & Evans, A.
- Affiliations
- University of South Australia (AU)
- Corresponding author
- Evans, Allan
- Venue
- Current Drug Metabolism
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2006-10-01
- Volume
- 7
- Issue
- 7
- Pages
- 811-816
- ISSN
- 1389-2002 (ISSN-L)
- OpenAlex
- W2157488905
- Cited by
- 29
- References
- 0
- Citations by year
- 2026: 2 · 2023: 2 · 2022: 1 · 2021: 1 · 2019: 1 · 2018: 1 · 2017: 5 · 2016: 2 · 2015: 2 · 2014: 5 · 2013: 1 · 2012: 3
- FWCI
- 0.23
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Drug Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- Topics
- Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Health Sciences › Nursing › Nutrition and Dietetics › Clinical Nutrition and Gastroenterology
- Keywords
- L-carnitine, trimethylamine, trimethylamine N-oxide, end-stage renal disease, hemodialysis, secondary carnitine deficiency, oral administration, plasma carnitine levels, dialysis clearance
- MeSH terms
- Administration, Oral, Adult, Aged, Carnitine, Renal Dialysis, Humans, Kidney Failure, Chronic, Male, Methylamines, Middle Aged
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.